Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GDA | Q9Y2T3 | 2/20 | 0.40 |
| ▸ | ATIC | P31939 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.32 |
| ▸ | POLB | P06746 | 1/20 | 0.32 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.32 |
| ▸ | SRC | P12931 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15759316 | 0.69 | GDA (0.39) | GDAATICALDH1A1POLBRXFP1 | |
| SCHEMBL10104693 | 0.62 | ALDH1A1 (0.38) | GDAATICALDH1A1 | |
| SCHEMBL28970653 | 0.61 | GDA (0.36) | GDAATIC | |
| SCHEMBL22647817 | 0.60 | GDA (0.32) | GDAATIC | |
| SCHEMBL1887298 | 0.58 | — | — | |
| SCHEMBL13735762 | 0.58 | ALDH1A1 (0.65) | GDAATICALDH1A1POLBRXFP1 | |
| SCHEMBL5752168 | 0.57 | — | — | |
| SCHEMBL13735766 | 0.56 | ALDH1A1 (0.63) | GDAATICALDH1A1POLBRXFP1 | |
| SCHEMBL12500558 | 0.56 | — | — | |
| SCHEMBL2523526 | 0.56 | GDA (0.51) | GDAATICALDH1A1POLBRXFP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 257 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1658081-A2 | IMMUNOSUPPRESSIVE EFFECTS OF PTERIDINE DERIVATIVES | 4 AZA Bioscience nv (BE) | 2006-05-24 | — | — | EP | claimed |
| WO-2005021003-A2 | IMMUNOSUPPRESSIVE EFFECTS OF PTERIDINE DERIVATIVES | 4 AZA BIOSCIENCE NV (BE) | 2005-03-10 | — | — | WO | claimed |
| US-20040077859-A1 | Immunosuppressive effects of pteridine derivatives | 4 AZA BIOSCIENCE NV (BE) | 2004-04-22 | — | — | US | claimed |
| US-20240231224-A9 | HALOGEN-AND ALIPHATIC-CONTAINING ORGANOTIN PHOTORESISTS AND METHODS THEREOF | LAM RESEARCH CORPORATION | 2024-07-11 | — | — | US | disclosed |
| WO-2024137876-A2 | SURFACE MODIFICATION OF METAL CATALYSTS WITH HYDROPHOBIC LIGANDS OR IONOMERS | TWELVE BENEFIT CORPORATION (US) | 2024-06-27 | — | — | WO | disclosed |
| US-20240200208-A1 | CO2 PURIFICATION AND REDUCTION SYSTEMS | SUMITOMO MITSUI BANKING CORPORATION | 2024-06-20 | — | — | US | disclosed |
| US-20240192590-A1 | APPARATUS AND PROCESS FOR EUV DRY RESIST SENSITIZATION BY GAS PHASE INFUSION OF A SENSITIZER | LAM RESEARCH CORPORATION | 2024-06-13 | — | — | US | disclosed |
| WO-2024123514-A1 | CO2 PURIFICATION AND REDUCTION SYSTEMS | TWELVE BENEFIT CORPORATION (US) | 2024-06-13 | — | — | WO | disclosed |
| WO-2024108304-A1 | DITHIOL CHELATORS FOR METAL CONJUGATION TO ANTIBODIES | STANDARD BIOTOOLS CANADA INC. (CA) | 2024-05-30 | — | — | WO | disclosed |
| US-20240134274-A1 | HALOGEN-AND ALIPHATIC-CONTAINING ORGANOTIN PHOTORESISTS AND METHODS THEREOF | LAM RES CORP (US) | 2024-04-25 | — | — | US | disclosed |
| WO-2024081174-A1 | OXYMETHYLENE COPOLYMERS FOR TRANSIENT SURFACE PROTECTION DURING CHEMICAL VAPOR DEPOSITION | LAM RESEARCH CORPORATION (US) | 2024-04-18 | — | — | WO | disclosed |
| WO-2005035121-A2 | SCHIFF BASE METAL COMPLEXES FOR USE AS CATALYSTS IN ORGANIC SYNTHESIS | UNIVERSITEIT GENT (BE) | 2005-04-21 | — | — | WO | disclosed |
| WO-2005025574-A2 | PTERIDINE DERIVATIVES FOR THE TREATMENT OF SEPTIC SHOCK AND TNF-α-RELATED DISEASES. | 4 AZA BIOSCIENCE NV (BE) | 2005-03-24 | — | — | WO | disclosed |
| WO-2005021003-A2 | IMMUNOSUPPRESSIVE EFFECTS OF PTERIDINE DERIVATIVES | 4 AZA BIOSCIENCE NV (BE) | 2005-03-10 | — | — | WO | disclosed |
| US-20050043541-A1 | Metal complexes useful in metathesis and other reactions | RIMTEC CORPORATION (JP) | 2005-02-24 | — | — | US | disclosed |
| WO-2004104005-A2 | IMMUNOSUPPRESSIVE EFFECTS OF PTERIDINE DERIVATIVES | 4 AZA BIOSCIENCE NV (BE) | 2004-12-02 | — | — | WO | disclosed |
| US-20040077859-A1 | Immunosuppressive effects of pteridine derivatives | 4 AZA BIOSCIENCE NV (BE) | 2004-04-22 | — | — | US | disclosed |
| EP-0733633-B1 | Heterocyclic compounds, their production and use | TAKEDA CHEMICAL INDUSTRIES LTD (JP) | 2003-05-28 | — | — | EP | disclosed |
| US-5753664-A | ANTITUMOR AGENTS, PYRIMIDONES | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1998-05-19 | — | — | US | disclosed |
| EP-0733633-A1 | Heterocyclic compounds, their production and use | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1996-09-25 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050043541-A1 | Metal complexes useful in metathesis and other reactions | TST, ETFA, TTPA | GDA 777/4885ATIC 344/4885ALDH1A1 214/4885 |
| US-20040077859-A1 | Immunosuppressive effects of pteridine derivatives | TPMT, NFATC1, MALT1 | GDA 1888/4885ATIC 1446/4885ALDH1A1 1257/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.